Dividends Calendar Earnings Calendar
PRTK

PRTK | Paratek Pharmaceuticals Inc

Paratek Pharmaceuticals Inc

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   Boston, Massachusetts, United States
  • Number of employees::   196

Company profile

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and?military use. The company's lead FDA approved commercial product, NUZYRA® (omadacycline) is a once-daily intravenous and oral antibiotic for the treatment of adult patients with CABP and ABSSSI caused by susceptible pathogens.

  • Subsidiaries:   Paratek Royalty Corporation, Paratek Pharma, LLC, Paratek Bermuda Ltd

Address

75 Park Plaza
4th Floor
Boston, MA 02116
United States

Products & Services

  • NUZYRA┬« (omadacycline)



    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    TwitterLinkedInYoutube

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.